CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Beijing Aosaikang Pharmaceutical Co Ltd Company Snapshot
Beijing Aosaikang Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Beijing Aosaikang Pharmaceutical Co Ltd with three other companies in this sector in CHINA : Xin Jiang Ready Health Industry Co Ltd (2019 sales of 4.50 billion Chinese Renmimbi [US$666.12 million] of which 55% was Pharmaceutical - Wholesale), Jiangsu Kanion Pharmaceutical Co., Ltd. (4.57 billion Chinese Renmimbi [US$675.92 million] of which 99% was Domestic Sales of Industrial Enterprises), and Tong Ren Tang Technologies Company Limited (4.48 billion Chinese Renmimbi [US$662.69 million] of which 63% was The Company).

Sales Analysis. Beijing Aosaikang Pharmaceutical Co Ltd reported sales of 4.52 billion Chinese Renmimbi (US$668.94 million) for the year ending December of 2019. This represents an increase of 14.9% versus 2018, when the company's sales were 3.93 billion Chinese Renmimbi. This was the third consecutive year of growth at Beijing Aosaikang Pharmaceutical Co Ltd. Sales of Pharmaceutical Manufacturing saw an increase of 15.4% in 2019, from 3.90 billion Chinese Renmimbi to 4.50 billion Chinese Renmimbi. Not all segments of Beijing Aosaikang Pharmaceutical Co Ltd experienced an increase in sales in 2019: sales of Others Business fell 46.8% to 16.33 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Beijing Aosaikang Pharmaceutical Co Ltd
  Stock Performance Chart for Beijing Aosaikang Pharmaceutical Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (9/11/2020): 17.26
(Figures in Chinese Renmimbi)
1 Week -6.1%   13 Weeks -11.1%  
4 Weeks -5.9%   52 Weeks 25.9%  
 
Beijing Aosaikang Pharmaceutical Co Ltd Key Data:
  Ticker: 002755 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 4,518,631,692
(Year Ending Jan 2020).
Employees: 2,049
  Currency: Chinese Renmimbi Market Cap: 16,020,047,658
  Fiscal Yr Ends: December Shares Outstanding: 928,160,351
  Share Type: A GU Closely Held Shares: 786,431,353
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.